<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03136731</url>
  </required_header>
  <id_info>
    <org_study_id>Celiac2017</org_study_id>
    <nct_id>NCT03136731</nct_id>
  </id_info>
  <brief_title>Evidence-based Screening Strategies for Celiac Disease</brief_title>
  <official_title>Improving Case-finding Strategies for Celiac Disease in Family Members: a Follow-up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katri Kaukinen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main aim: To find evidence-based screening strategies for celiac disease in high risk groups
      and to find new biomarkers or biomarker combinations for celiac disease diagnostics and
      follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current project will result in the identification of genetic, environmental or downstream
      biomedical markers that predict the development of celiac disease at the individual level.
      Moreover, the markers can be exploited in prediction of specific disease risks,
      manifestations, comorbidities and complications.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 29, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2032</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Forthcoming celiac disease diagnosed by current diagnostic criteria</measure>
    <time_frame>With in 10 years</time_frame>
    <description>Assessed by positive transglutaminase antibodies, small bowel mucosal villous atrophy</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3517</enrollment>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>Healthy family members of celiac disease</arm_group_label>
    <description>Celiac disease screening, no intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Celiac disease index cases</arm_group_label>
    <description>Assessment of disease related factors, no intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Celiac disease antibody screening</intervention_name>
    <description>Observational parameters</description>
    <arm_group_label>Healthy family members of celiac disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Volunteers; cohort 1, 3217 genetically predisposed healthy family members of celiac disease
        patients (high risk group for celiac disease), Cohort 2, 200 new celiac disease index cases
        will be enrolled
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cohort 1: Family member of celiac disease patient

          -  Cohort 2: Previously diagnosed celiac disease

        Exclusion Criteria:

          -  Cohort 1: No previous celiac disease

          -  Cohort 2: Celiac disease diagnosis not confirmed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tampere University Hospital / Tampere University</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2017</study_first_posted>
  <last_update_submitted>September 20, 2019</last_update_submitted>
  <last_update_submitted_qc>September 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Katri Kaukinen</investigator_full_name>
    <investigator_title>Professor, MD PhD</investigator_title>
  </responsible_party>
  <keyword>Celiac disease, Gluten, Microbiome, Genetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

